Esculentin (1-21)

General Information


DRACP ID  DRACP01005

Peptide Name   Esculentin (1-21)

Sequence  GIFSKLAGKKIKNLLISGLKG

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma 50% Cell death=150 µM MTT assay 24h 1

Hemolytic Activity  Sheep erythrocytes: 10% Hemolysis=64 µM

Normal (non-cancerous) Cytotoxicity  HaCat: 20% Killing=64 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01005

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C102H181N27O25

Absent amino acids  CDEHMPQRTVWY

Common amino acids  K

Mass  254266

Pl  11.4

Basic residues  5

Acidic residues  0

Hydrophobic residues  9

Net charge  5

Boman Index  180

Hydrophobicity  33.81

Aliphatic Index  134.76

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32722535

Title  Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities

Doi 10.3390/antibiotics9080448

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.